IRADIMED CORP·4

Jan 21, 4:05 PM ET

Susi Roger E. 4

Research Summary

AI-generated summary

Updated

IRADIMED (IRMD) 10% Owner Roger Susi Sells Shares

What Happened
Roger E. Susi, listed as a 10% owner of IRADIMED Corp (IRMD), sold a total of 5,000 shares in open-market transactions on January 20, 2026, for aggregate proceeds of approximately $509,225. The sales were reported as three disposals: 2,129 shares at a weighted average price of $101.03 (≈ $215,093), 1,074 shares at $102.03 (≈ $109,580), and 1,797 shares at $102.70 (≈ $184,552). These were sales (S) — routine dispositions rather than purchases or option exercises.

Key Details

  • Transaction date: January 20, 2026; Form 4 filed January 21, 2026 (appears timely under Section 16 reporting requirements).
  • Individual trade details:
    • 2,129 shares @ $101.03, proceeds ≈ $215,093 (weighted avg; underlying prices $100.50–$101.48).
    • 1,074 shares @ $102.03, proceeds ≈ $109,580 (weighted avg; underlying prices $101.56–$102.48).
    • 1,797 shares @ $102.70, proceeds ≈ $184,552 (weighted avg; underlying prices $102.62–$102.86).
  • Total: 5,000 shares sold for ≈ $509,225.
  • Sales were made pursuant to a Rule 10b5-1 trading plan adopted June 16, 2025 (Footnote F1).
  • Reporting person disclaims beneficial ownership except to extent of pecuniary interest (Footnote F5).
  • Shares owned after the transactions: not disclosed in the information provided in this summary.

Context

  • A Rule 10b5-1 plan allows insiders to pre-arrange trades; such sales often reflect pre-set plans or portfolio management rather than a contemporaneous view on the company.
  • Because this is a sale by a 10% owner (a significant shareholder), retail investors should note the size of the holder but avoid assuming the sale signals company fundamentals without additional information.